/Investor DB

Platanus Ventures — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Nuvig Therapeuticsnuvigtx.comDec 2024

Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function.

BiotechLongevity

Co-investorsSanofi Venturesabrdn plcAlexandriaB CapitalDigitalis VenturesGlobal BioAccess Fund+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.